T1	Organism 14 36	Pseudomonas aeruginosa
T2	Organism 253 261	patients
T3	Organism 302 315	P. aeruginosa
T4	Organism 690 703	P. aeruginosa
T5	Organism 864 877	P. aeruginosa
T6	Organism 1062 1075	P. aeruginosa
T7	Organism 1114 1122	patients
T8	Chemical 1264 1290	alginate exopolysaccharide
T9	Chemical 1292 1295	EPS
T10	Chemical 1307 1315	Alginate
T11	Organism 1375 1386	Pseudomonas
T12	Organism 1490 1498	patients
T13	Organism 1536 1549	P. aeruginosa
T14	Chemical 1578 1586	alginate
T15	Organism 1739 1752	P. aeruginosa
T16	Organism 1787 1795	patients
T17	Chemical 2454 2466	beta-lactams
T18	Chemical 2471 2486	aminoglycosides
T19	Chemical 2693 2696	EPS
T20	Organism 3695 3703	patients
T21	Organism 3882 3895	P. aeruginosa
T22	Organism 3897 3906	S. aureus
T23	Organism 3908 3915	E. coli
T24	Organism 3920 3931	V. fischeri
T25	Protein 4446 4450	GacA
T26	Protein 4611 4615	LadS
T27	Protein 4620 4624	RetS
T28	Protein 4652 4656	GacA
T29	Protein 4735 4739	algR
T30	Organism 4904 4917	P. aeruginosa
T31	Protein 5031 5035	SadA
T32	Protein 5035 5036	R
T33	Protein 5036 5037	S
T34	Protein 5101 5105	PvrR
T35	Organism 5208 5221	P. aeruginosa
T36	Chemical 5412 5443	cationic antimicrobial peptides
T37	Chemical 5445 5449	CAPs
T38	Chemical 5526 5530	CAPs
T39	Chemical 5699 5703	CAPs
T40	Organism 5836 5842	humans
T41	Organism 6030 6043	P. aeruginosa
T42	Chemical 6059 6063	CAPs
T43	Two-component-system 6084 6089	PhoPQ
T44	Protein 6084 6088	PhoP
T45	Protein 6088 6089	Q
T46	Two-component-system 6094 6099	PmrAB
T47	Protein 6094 6098	PmrA
T48	Protein 6098 6099	B
T49	Chemical 6172 6176	Mg2+
T50	Chemical 6217 6226	magnesium
T51	Protein 6228 6232	PhoP
T52	Protein 6237 6241	PmrA
T53	Chemical 6270 6273	CAP
T54	Regulon-operon 6292 6305	PA3552-PA3559
T55	Protein 6292 6298	PA3552
T56	Protein 6299 6305	PA3559
T57	Regulon-operon 6307 6321	arnBCADTEF-ugd
T58	Protein 6307 6311	arnB
T59	Protein 6311 6312	C
T60	Protein 6312 6313	A
T61	Protein 6313 6314	D
T62	Protein 6314 6315	T
T63	Protein 6315 6316	E
T64	Protein 6316 6317	F
T65	Protein 6318 6321	ugd
T66	Chemical 6382 6385	LPS
T67	Chemical 6454 6461	lipid A
T68	Chemical 6500 6504	CAPs
T69	Two-component-system 6515 6520	PhoPQ
T70	Protein 6515 6519	PhoP
T71	Protein 6519 6520	Q
T72	Two-component-system 6525 6530	PmrAB
T73	Protein 6525 6529	PmrA
T74	Protein 6529 6530	B
T75	Chemical 6641 6645	CAPs
T76	Chemical 6665 6669	Mg2+
T77	Regulon-operon 6706 6719	PA3552-PA3559
T78	Protein 6706 6712	PA3552
T79	Protein 6713 6719	PA3559
T80	Organism 7012 7025	P. aeruginosa
T81	Chemical 7092 7110	exopolysaccharides
T82	Organism 7903 7916	P. aeruginosa
T83	Organism 8015 8028	P. aeruginosa
T84	Organism 8132 8158	Staphylococcus epidermidis
*	Equiv T36 T37
*	Equiv T54 T57
T85	Process 108 118	infections
T86	Process 164 174	infections
T87	Process 447 456	infection
T88	Process 624 634	resistance
T89	Process 749 757	tolerant
T90	Positive_regulation 946 955	increased
T91	Process 956 966	resistance
T92	Process 1481 1489	infected
T93	Process 1845 1855	resistance
T94	Process 1901 1911	resistance
T95	Process 2066 2076	resistance
T96	Process 2203 2213	resistance
T97	Process 3016 3026	resistance
T98	Process 3201 3211	resistance
T99	Process 3433 3443	infections
T100	Process 3522 3532	resistance
T101	Process 3622 3632	resistance
T102	Process 3727 3737	infections
T103	Process 4419 4428	virulence
T104	Regulation 4635 4648	work upstream
T105	Process 5181 5190	resistant
T106	Process 5311 5320	infection
T107	Process 6045 6055	resistance
T108	Positive_regulation 6067 6076	inducible
T109	Positive_regulation 6124 6133	activated
T110	Binding 6242 6246	bind
T111	Process 6274 6284	resistance
T112	Positive_regulation 6327 6333	induce
T113	Gene_expression 6338 6348	expression
T114	Process 6627 6637	resistance
T115	Gene_expression 6751 6760	expressed
T116	Process 6972 6982	resistance
T117	Process 8290 8300	resistance
T118	Process 8440 8450	resistance
E1	Process:T85 Participant:T1
E2	Process:T86 
E3	Process:T87 
E4	Process:T88 
E5	Process:T89 
E6	Positive_regulation:T90 Theme:E7
E7	Process:T91 
E8	Process:T92 
E9	Process:T93 
E10	Process:T94 
E11	Process:T95 
E12	Process:T96 
E13	Process:T97 
E14	Process:T98 
E15	Process:T99 
E16	Process:T100 
E17	Process:T101 
E18	Process:T102 
E19	Process:T103 
E20	Regulation:T104 Theme:T28 Cause:T26
E21	Regulation:T104 Theme:T28 Cause:T27
E22	Process:T105 Participant:T35
E23	Process:T106 
E24	Process:T107 Participant:T41
E25	Positive_regulation:T108 Theme:E24 Cause:T43
E26	Positive_regulation:T108 Theme:E24 Cause:T46
E27	Positive_regulation:T109 Theme:T43
E28	Positive_regulation:T109 Theme:T46
E29	Binding:T110 Theme1:T51 Theme2:T54
E30	Binding:T110 Theme1:T52 Theme2:T54
E31	Process:T111 
E32	Positive_regulation:T112 Theme:E34 Cause:T51
E33	Positive_regulation:T112 Theme:E34 Cause:T52
E34	Gene_expression:T113 Theme:T54
E35	Process:T114 
E36	Gene_expression:T115 Theme:T77
E37	Process:T116 
E38	Process:T117 
E39	Process:T118 
T119	Span 1510 1709	The direct observation of P. aeruginosa microcolonies encased in an alginate matrix in microscopy studies of CF bronchial samples [17], along with a large body of additional in vitro and in vivo data
T120	Causality 1725 1738	suggests that
E40	Causality:T120 Effect:T121 Evidence:T119
T121	Span 1739 1795	P. aeruginosa forms biofilms in the lungs of CF patients
T122	Span 2215 2275	Cells in a biofilm may be protected from antibiotic exposure
T123	Causality 2276 2282	due to
E41	Causality:T123 Effect:T122 Evidence:T124
T124	Span 2283 2351	the restricted penetration of antibiotics through the biofilm matrix
T125	Span 5654 5752	The broad-spectrum antimicrobial activity of CAPs against Gram-negative and Gram-positive bacteria
T126	Causality 5753 5765	accounts for
E42	Causality:T126 Effect:T127 Evidence:T125
T127	Span 5766 5863	their role as an essential component of the innate immune response of humans, animals and insects
